Lyka Labs Ltd
has announced that Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited, has launched two domestic marketing divisions in the name of ENSPAN and CERABELLE. Enspan would be marketing Critical and Anesthesia range of Products and Cerabelle would be marketing Dermatology and Cosmetology range of Products.
The above products would also be offered internationally in the 46 countries in which Lyka has its presence.
Lyka Labs Ltd is currently trading at Rs. 83.25, up by Rs. 0.55 or 0.67% from its previous closing of Rs. 82.7 on the BSE.
The scrip opened at Rs. 83.3 and has touched a high and low of Rs. 84.7 and Rs. 82 respectively. So far 74034(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 182.27 crore.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 142.9 on 26-Nov-2015 and a 52 week low of Rs. 50.25 on 28-Apr-2015. Last one week high and low of the scrip stood at Rs. 85.5 and Rs. 78.7 respectively.
The promoters holding in the company stood at 24.9 % while Institutions and Non-Institutions held 0.84 % and 74.27 % respectively.
The stock is currently trading above its 200 DMA.